Tumor necrosis factor-α suppresses the expression of steroid receptor coactivator-1 and-2:: A possible mechanism contributing to changes in steroid hormone responsiveness

被引:29
作者
Leite, RS [1 ]
Brown, AG [1 ]
Strauss, JF [1 ]
机构
[1] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA
关键词
progesterone receptor; uterine smooth muscle cells; parturition; cofactors; inflammation;
D O I
10.1096/fj.04-1684fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammation is associated in some tissues with diminished responsiveness to steroid hormone action. We hypothesized that proinflammatory cytokines alter steroid hormone sensitivity, in part, by reducing levels of key nuclear receptor coactivators. Treatment of cultured human uterine smooth muscle cells (UtSMC) with TNF-alpha significantly reduced mRNA for the coactivators, SRC-1 (42%, P< 0.01) and 2 (47%, P< 0.03), and diminished the respective protein levels, but did not significantly alter the mRNAs encoding SRC-3, CBP and the corepressors, NCoR and SMRT; or progesterone receptor protein levels. To assess TNF-alpha effects on steroid hormone-mediated transcriptional activity, UtSMC were transfected with progesterone receptor B (PR-B) and a model PRE(2)-luciferase reporter construct. Transfected UtSMC were treated with progesterone alone or in the presence of TNF-alpha, and assayed for luciferase activity. TNF-alpha (10 ng/ml) diminished progesterone-stimulated PR-B-mediated transactivation by similar to60% (P< 0.02). The TNF-alpha-dependent decrease in PRE-luciferase activity was fully prevented by cotransfection with SRC-2, and partially prevented with exogenous SRC-1. In conclusion, TNF-alpha impairs progesterone-stimulated PR-B-mediated transactivation, and these effects appear to be due, in part, to reduced expression of SRC-1 and -2, which is a novel mechanism by which inflammation can functionally block steroid hormone action.
引用
收藏
页码:1418 / +
页数:17
相关论文
共 38 条
[11]   The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT [J].
Jackson, TA ;
Richer, JK ;
Bain, DL ;
Takimoto, GS ;
Tung, L ;
Horwitz, KB .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (06) :693-705
[12]   Steroid receptor induction of gene transcription: A two-step model [J].
Jenster, G ;
Spencer, TE ;
Burcin, MM ;
Tsai, SY ;
Tsai, MJ ;
OMalley, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :7879-7884
[13]   Negative interaction between the RelA(p65) subunit of NF-kappa B and the progesterone receptor [J].
Kalkhoven, E ;
Wissink, S ;
vanderSaag, PT ;
vanderBurg, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6217-6224
[14]   2 DISTINCT ESTROGEN-REGULATED PROMOTERS GENERATE TRANSCRIPTS ENCODING THE 2 FUNCTIONALLY DIFFERENT HUMAN PROGESTERONE-RECEPTOR FORM-A AND FORM-B [J].
KASTNER, P ;
KRUST, A ;
TURCOTTE, B ;
STROPP, U ;
TORA, L ;
GRONEMEYER, H ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (05) :1603-1614
[15]   Cytokines, prostaglandins and parturition - A review [J].
Keelan, JA ;
Blumenstein, M ;
Helliwell, RJA ;
Sato, TA ;
Marvin, KW ;
Mitchell, MD .
PLACENTA, 2003, 24 :S33-S46
[16]   The molecular mechanisms of term and preterm labor: Recent progress and clinical implications [J].
Keelan, JA ;
Coleman, M ;
Mitchell, MD .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1997, 40 (03) :460-478
[17]  
Kurebayashi J, 2000, CLIN CANCER RES, V6, P512
[18]   MICE LACKING PROGESTERONE-RECEPTOR EXHIBIT PLEIOTROPIC REPRODUCTIVE ABNORMALITIES [J].
LYDON, JP ;
DEMAYO, FJ ;
FUNK, CR ;
MANI, SK ;
HUGHES, AR ;
MONTGOMERY, CA ;
SHYAMALA, G ;
CONNEELY, OM ;
OMALLEY, BW .
GENES & DEVELOPMENT, 1995, 9 (18) :2266-2278
[20]   Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways [J].
McKay, LI ;
Cidlowski, JA .
ENDOCRINE REVIEWS, 1999, 20 (04) :435-459